These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20176717)

  • 41. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
    Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
    J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
    Lisy O; Lainchbury JG; Leskinen H; Burnett JC
    Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
    Ferreira A; Bettencourt P; Pimenta J; Friões F; Pestana M; Soares-da-Silva P; Cerqueira-Gomes M
    Am Heart J; 2002 Mar; 143(3):391-7. PubMed ID: 11868042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.
    Boerrigter G; Costello-Boerrigter LC; Harty GJ; Huntley BK; Cataliotti A; Lapp H; Burnett JC
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1744-50. PubMed ID: 19386989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.
    Owan TE; Chen HH; Frantz RP; Karon BL; Miller WL; Rodeheffer RJ; Hodge DO; Burnett JC; Redfield MM
    J Card Fail; 2008 May; 14(4):267-75. PubMed ID: 18474338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure.
    Kiuchi S; Ikeda T
    Intern Med; 2019 Feb; 58(4):471-475. PubMed ID: 30210135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in natriuretic peptides in congestive heart failure.
    Boerrigter G; Burnett JC
    Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects.
    Brunner-La Rocca HP; Kaye DM; Woods RL; Hastings J; Esler MD
    J Am Coll Cardiol; 2001 Apr; 37(5):1221-7. PubMed ID: 11300426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Normotensive sodium loading in conscious dogs: regulation of renin secretion during beta-receptor blockade.
    Bie P; Mølstrøm S; Wamberg S
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R428-35. PubMed ID: 19073902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.
    Boerrigter G; Costello-Boerrigter LC; Cataliotti A; Lapp H; Stasch JP; Burnett JC
    Hypertension; 2007 May; 49(5):1128-33. PubMed ID: 17325237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure.
    Zhang PL; Mackenzie HS; Totsune K; Troy JL; Brenner BM
    Circ Res; 1995 Dec; 77(6):1240-5. PubMed ID: 7586237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Continuous Administration of Tolvaptan on Preventing Medium-Term Worsening Renal Function and Long-Term Adverse Events in Heart Failure Patients with Chronic Kidney Disease.
    Nakano Y; Mizuno T; Niwa T; Mukai K; Wakabayashi H; Watanabe A; Ando H; Takashima H; Murotani K; Waseda K; Amano T
    Int Heart J; 2018 Jan; 59(1):105-111. PubMed ID: 29332911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2007 Nov; 74(10):1466-75. PubMed ID: 17720144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure.
    Hori M
    Future Cardiol; 2013 Mar; 9(2):163-76. PubMed ID: 23463968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?
    Thireau J; Karam S; Roberge S; Roussel J; Aimond F; Cassan C; Gac A; Babuty D; Le Guennec JY; Lacampagne A; Fauconnier J; Richard S
    Heart; 2014 Jun; 100(11):833-41. PubMed ID: 24667281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Pedersen EB
    Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.